[HTML][HTML] RdRp inhibitors and COVID-19: Is molnupiravir a good option?

SMR Hashemian, MH Pourhanifeh, MR Hamblin… - Biomedicine & …, 2022 - Elsevier
Rapid changes in the viral genome allow viruses to evade threats posed by the host immune
response or antiviral drugs, and can lead to viral persistence in the host cells. RNA …

The flavivirus NS2B–NS3 protease–helicase as a target for antiviral drug development

D Luo, SG Vasudevan, J Lescar - Antiviral research, 2015 - Elsevier
The flavivirus NS3 protein is associated with the endoplasmic reticulum membrane via its
close interaction with the central hydrophilic region of the NS2B integral membrane protein …

Structure of the SARS-CoV nsp12 polymerase bound to nsp7 and nsp8 co-factors

RN Kirchdoerfer, AB Ward - Nature communications, 2019 - nature.com
Recent history is punctuated by the emergence of highly pathogenic coronaviruses such as
SARS-and MERS-CoV into human circulation. Upon infecting host cells, coronaviruses …

Current trends and limitations in dengue antiviral research

JO Obi, H Gutiérrez-Barbosa, JV Chua… - Tropical Medicine and …, 2021 - mdpi.com
Dengue is the most prevalent arthropod-borne viral disease worldwide and affects
approximately 2.5 billion people living in over 100 countries. Increasing geographic …

Targeting the RdRp of emerging RNA viruses: the structure-based drug design challenge

F Picarazzi, I Vicenti, F Saladini, M Zazzi, M Mori - Molecules, 2020 - mdpi.com
The RNA-dependent RNA polymerase (RdRp) is an essential enzyme for the viral
replication process, catalyzing the viral RNA synthesis using a metal ion-dependent …

Molecular mechanisms of antiviral agents against dengue virus

MF Lee, YS Wu, CL Poh - Viruses, 2023 - mdpi.com
Dengue is a major global health threat causing 390 million dengue infections and 25,000
deaths annually. The lack of efficacy of the licensed Dengvaxia vaccine and the absence of …

The dengue virus NS5 protein as a target for drug discovery

SP Lim, CG Noble, PY Shi - Antiviral research, 2015 - Elsevier
The non-structural protein 5 (NS5) of flaviviruses is the most conserved amongst the viral
proteins. It is about 900 kDa and bears enzymatic activities that play vital roles in virus …

The many faces of the flavivirus NS5 protein in antagonism of type I interferon signaling

SM Best - Journal of virology, 2017 - Am Soc Microbiol
The vector-borne flaviviruses cause severe disease in humans on every inhabited continent
on earth. Their transmission by arthropods, particularly mosquitoes, facilitates large …

Molecular insights into the flavivirus replication complex

K Van den Elsen, JP Quek, D Luo - Viruses, 2021 - mdpi.com
Flaviviruses are vector-borne RNA viruses, many of which are clinically relevant human viral
pathogens, such as dengue, Zika, Japanese encephalitis, West Nile and yellow fever …

Flavivirus nonstructural proteins and replication complexes as antiviral drug targets

K van den Elsen, BLA Chew, JS Ho, D Luo - Current opinion in virology, 2023 - Elsevier
Highlights•Molecular structures and predicated models of flaviviral NS proteins.•Recent
advance in antiviral development targeting NS proteins.•Inhibitors targeting NS4B entering …